1. BCL‐2 levels do not predict azathioprine treatment response in inflammatory bowel disease, but inhibition induces lymphocyte apoptosis and ameliorates colitis in mice. (21st September 2018) Authors: Weder, B.; Mozaffari, M.; Biedermann, L.; Mamie, C.; Moncsek, A.; Wang, L.; Clarke, S. H.; Rogler, G.; McRae, B. L.; Graff, C. L.; Ruiz, P. A.; Hausmann, M. Journal: Clinical and experimental immunology Issue: Volume 193:Number 3(2018:Sep.) Page Start: 346 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. Increased lymphocyte apoptosis in mouse models of colitis upon ABT‐737 treatment is dependent upon BIM expression. (19th May 2015) Authors: Lutz, C.; Mozaffari, M.; Tosevski, V.; Caj, M.; Cippà, P.; McRae, B. L.; Graff, C. L.; Rogler, G.; Fried, M.; Hausmann, M. Journal: Clinical and experimental immunology Issue: Volume 181:Number 2(2015:Aug.) Page Start: 343 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Increased lymphocyte apoptosis in mouse models of colitis upon ABT‐737 treatment is dependent upon BIM expression. (19th May 2015) Authors: Lutz, C.; Mozaffari, M.; Tosevski, V.; Caj, M.; Cippà, P.; McRae, B. L.; Graff, C. L.; Rogler, G.; Fried, M.; Hausmann, M. Journal: Clinical and experimental immunology Issue: Volume 181:Number 2(2015:Aug.) Page Start: 343 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗